secwatch / observer
8-K filed April 22, 2026, 7:59 PM ET ticker ELV CIK 0001156039
earnings confidence high sentiment positive materiality 0.78

Elevance Health Q1 adj EPS $12.58 beats; raises FY2026 adj EPS guidance to at least $26.75

Elevance Health, Inc.

2026-Q1 EPS reported $8.00 vs consensus $10.93 ▼ miss (-26.8%)

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Elevance Health, Inc. reported FY 2026 results: EPS at least $26.75. Guidance raised.

Period
FY 2026
EPS
at least $26.75
Guidance
raised
Result
guidance update
Exact text from the filing
FY 2026 adjusted diluted EPS 2 guidance raised to at least $26.75, supported by underlying business strength, actions to reduce medical costs, and increased visibility
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Elevance Health, Inc. reported first quarter 2026 results: revenue $49.5 billion, EPS $8.00. Guidance raised.

Period
first quarter 2026
Revenue
$49.5 billion
EPS
$8.00
Guidance
raised
Result
reported results
Exact text from the filing
ELEVANCE HEALTH REPORTS FIRST QUARTER 2026 RESULTS; RAISES FULL-YEAR GUIDANCE • 1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 • 1Q 2026 diluted EPS 1 of $8.00; adjusted diluted EPS 2 of $12.58 driven by strong operating results and ~$1 per share of non-recurring investment income
View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

Elevance Health, Inc. filing history →

Source: SEC EDGAR
accession 0001156039-26-000039
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.